TITLE

The Role of Fibrinolysis in the Therapy of Peripheral Vascular Disease

AUTHOR(S)
Ambrus, Clara M.; Ambrus, Julian L.; Gastpar, Helmuth; Sharma, Satya D.; Suh, O. W.; Moore, Robert H.; Williams, Phyllis
PUB. DATE
July 1984
SOURCE
Angiology;Jul1984, Vol. 35 Issue 7, p436
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In vivo thrombolytic studies in stumptailed monkeys indicated that pentoxifylline potentiates thrombolysis induced by urokinase activated human plasmin. Pentoxifylline as well as prostaglandin E1 released plasminogen activators and activated the fibrinolysin system. From this point of view pentoxifylline and prostaglandin E1 synergized with each other. Pentoxifylline potentiated the thrombolytic effect of prostaglandin E1 in vivo.
ACCESSION #
16352719

 

Related Articles

  • The Biochemical and Physical Process of Fibrinolysis and Effects of Clot Structure and Stability on the Lysis Rate. Weisel, J. W.; Litvinov, R. I. // Cardiovascular & Hematological Agents in Medicinal Chemistry;2008, Vol. 6 Issue 3, p161 

    The effectiveness of fibrinolysis results from the combination of regulated enzymatic activity and the physical properties of the fibrin scaffold. Physiologically, clots or thrombi are dissolved from within via internal lysis. In contrast, with therapeutic thrombolysis, lytic agents are...

  • Hyperfibrinolysis - is it common? Measurement and treatment including the role of thromboelastography. Carey, Michelle; Cressey, David Martin // Clinical Risk;Sep2009, Vol. 15 Issue 5, p188 

    The article discusses the treatment of hyperfibrinolysis through thromboelastography. It states that fibrinolysis is the breakdown of unchanging strands of fibrin by plasmin. It notes that plasminogen is a static precursor combined in the liver that disseminates in the plasma and is integrated...

  • Development of New Fibrinolytic Agents. Ueshima, Shigeru; Matsuo, Osamu // Current Pharmaceutical Design;Mar2006, Vol. 12 Issue 7, p849 

    Since the activation of coagulation system and platelets triggers the thrombosis, the agents possessing anticoagulation or anti-platelet function have been used for the antithrombotic procession actions. However, in the physiological condition, the fibrinolytic system serves as antithrombotic,...

  • THROMBOLYTIC THERAPY. Loewe, Leo; Halpern, Alfred // Angiology;May1961, Vol. 12 Issue 5, p147 

    Discusses the fibrinolytic treatment of thromboembolic disease. Potential of fibrinolysin, a fibrinolytic agent to dissolve thrombi within the circulation; Capacity to dissolve the fibrin binding the clot without affecting the other proteins in the blood producing adverse reactions; Influence of...

  • FIBRINOLYSIN THERAPY IN THROMBOEMBOLIC DISEASE. Randolph, W. Alan; Starling, Howard M. // Angiology;May1961, Vol. 12 Issue 5, p179 

    Reports on the aid of fibrinolysin therapy in thromboembolic disease. Toxicity of the agent as indicated by the relatively small number of toxic responses; Indication of a negative hemorrhagic complications caused by the drug; Demonstration of drug efficacy in the drug.

  • Antiplatelet Agents Can Promote Two-Peaked Thrombin Generation in Platelet Rich Plasma: Mechanism and Possible Applications. Tarandovskiy, Ivan D.; Artemenko, Elena O.; Panteleev, Mikhail A.; Sinauridze, Elena I.; Ataullakhanov, Fazoil I. // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Background: Thrombin generation assay is a convenient and widely used method for analysis of the blood coagulation system status. Thrombin generation curve (TGC) is usually bell-shaped with a single peak, but there are exceptions. In particular, TGC in platelet-rich plasma (PRP) can sometimes...

  • Fibrinolytic Therapy in Acute Stroke. Mill�n, M�nica; Dorado, Laura; D�valos, Antoni // Current Cardiology Reviews;2010, Vol. 6 Issue 3, p218 

    Acute ischemic stroke is a major cause of morbidity and mortality in Europe, North America, and Asia. Its treatment has completely changed over the past decade with different interventional approaches, such as intravenous trials, intra-arterial trials, combined intravenous/intra-arterial trials,...

  • Single versus bilateral external ventricular drainage for intraventricular fibrinolysis in severe ventricular haemorrhage. D Staykov // Journal of Neurology, Neurosurgery & Psychiatry;Jan2010, Vol. 81 Issue 1, p105 

    BACKGROUND: Intraventricular fibrinolysis (IVF) through bilateral external ventricular drains (EVD) may provide better access of the thrombolytic agent to the intraventricular clot, potentially influencing clot clearance and outcome. METHODS: Patients with spontaneous ganglionic intracerebral...

  • Is Thrombolysis of Venous Thrombosis an Option in Treatment? Cairols, Marc A. // Vascular Surgery;Nov/Dec1996, Vol. 30 Issue 6, p451 

    Explores the role of thrombolysis in the treatment of acute deep vein thrombosis (DVT). Benefits of lytic therapy; Use of fibrinolytic therapy in DVT treatment; Outcome of catheter directed thrombolysis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics